Effect of different hormonal replacement therapies on circulating allopregnanolone and dehydroepiandrosterone levels in postmenopausal women

References

• Akwa Y, Baulieu EE. Neurosteroids: behavioral aspects and physiological implications. J Soc Biol 1999;193:293–8
   PubMedGoogle Scholar
• Mellon SH. Neurosteroids: action and clinical relevance. J Clin Endocrinol Metab 1994;78:1003–8
   PubMed Web of Science ®Google Scholar
• Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABA A receptors. Mechanism of action and physiological signifi-cance. Prog Neurobiol 1992;38:379–95
   Google Scholar
• Wolf OT, Neumenm O, Helhammer DH, et al. Effects of a two-week physiological dehydro-epiandrosterone substitution on cognitive perfor-mance and well-being in healthy elderly women and men. J Clin Endocrinol Metab 1997;82:2363–7
   PubMed Web of Science ®Google Scholar
• Monteleone P, Luisi S, Tonetti A, et al. Allo-pregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 2000;142:269–73
   PubMed Web of Science ®Google Scholar
• Palombo MA, Salvestroni C, Gallo R, et al. Allo-pregnanolone concentrations in hippocampus of prepubertal rats and female rats throughout estrous cycle. J Endocrinol Invest 1995;18:853–6
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Petraglia F, Bernardi F, et al. Circulating levels of allopregnanolone in humans: gender, age and endocrine influences. J Clin Endo-crinol Metab 1998;83:2099–103
   PubMed Web of Science ®Google Scholar
• Schumacher M, Coirini H, McEwen BS. Regula-tion of high affinity GABAA receptors in the dorsal hippocampus by estradiol and progesteron. Brain Res 1989;487:178–84
   Google Scholar
• Serra M, Pisu MG, Lettera M, et al. Social isola-tion-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor func-tion in rat brain. J Neurochem 2000;75:732–40
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Bernardi F, Stomati M, et al. Effects of estradiol and raloxifene analog on brain, adrenal and serum allopregnanolone content in fertile and ovariectomized female rats. Neuroendocrinology 2000;72:162–70
   PubMed Web of Science ®Google Scholar
• Stomati M, Bersi C, Rubino S, et al. Neuro-endocrine effects of different oestradiol—progestin regimen in postmenopausal women. Maturitas 1997;28:127–35
   PubMed Web of Science ®Google Scholar
• Lephart ED, Simpson ER, Trzeciak WH. Rat adrenal 5-alpha-reductase mRNA content and enzyme activity are sex hormone dependent. JMol Endocrinol 1991;6: 163–70
   Google Scholar
• Genazzani AR, Palumbo MA, de Micheroux AA, et al. Evidence for a role for the neurosteroid allopregnanolone in the modulation on reproduc-tive function in female rats. Eur J Endocrinol 1995;133:375–80
   PubMed Web of Science ®Google Scholar
• Laconi MR, Casteller G, Gargiulo PA, et al. The anxiolytic effect of allopregnanolone is associated with gonadal hormonal status in female rats. Eur J Pharmacol 2001;417:111–16
   PubMed Web of Science ®Google Scholar
• Wilson MA. Influences of gender, gonadectomy and estrous cycle on GABA/BZ receptors and benzodiazepine responses in rats. Brain Res Bull 1992;29:165–72
   PubMed Web of Science ®Google Scholar
• Schumacher M, Coirini H, Robert F, et al. Genomic and membrane actions of progesterone: implications for reproductive physiology and behavior. Behav Brain Res 1999;105:37–52
   PubMed Web of Science ®Google Scholar
• Yamaji T, Ibayashi H. Serum dehydroepiandro-sterone sulphate in normal and pathological condi-tions. J Clin Endocrinol Metab 1969;29:273–78
   PubMed Web of Science ®Google Scholar
• Parker LN, Odell WD. Control of adrenal androgen secretion. Endocr Rev 1980;4:392–410
   Google Scholar
• Corpechot C, Robert P, Axelson M, et al. Charac-terization and measurement of dehydroepiandro-sterone sulfate in the rat brain. Proc Natl Acad Sci USA 1981;78:4704–7
   PubMed Web of Science ®Google Scholar
• Davis SR, Burger HG. Androgens and the post-menopausal woman. Clinical Review 82. J Clin Endocrinol Metab 1996;81:2759–63
   PubMed Web of Science ®Google Scholar
• Majewska MD, Demirgoren S, Spivak CE, et al. The neurosteroid DHEA is an allosteric antagonist of the GABA A receptor. Brain Res 1990;526: 143–6
   PubMed Web of Science ®Google Scholar
• Baulieu EE. Dehydroepiandrosterone: a fountain ofyouth? J Clin Endocrinol Metab 1996;81:3147–51
   PubMed Web of Science ®Google Scholar
• Thijss en JH, Nieuwenhuyse H. DHEA: a Compre-hensive Review. Carnforth, UK: Parthenon Publishing, 1999
   Google Scholar
• Rubino S, Stomati M, Bersi C, et al. Neuro-endocrine effect of a short-term treatment with DHEA in postmenopausal women. Maturitas 1998;28:251–7
   PubMed Web of Science ®Google Scholar
• Taelman P, Kaufman JM, Janssens X, et al. Persistence of increased bone-resumption and possible role of dehydroepiandrosterone as a bone metabolism determinant in osteoporotic women in late menopause. Maturitas 1989;11:65–73
   PubMed Web of Science ®Google Scholar
• Nordin BEG, Robertson A, Seamark RF. The relation between calcium absorption, serum DHEA and vertebral mineral density in post-menopausal women. J Clin Endocrinol Metab 1985; 60:651–7
   Google Scholar
• Wolkowitz OM, Reus VI, Roberts E, et al. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 1997;41:311–18
   PubMed Web of Science ®Google Scholar
• Stomati M, Monteleone P, Casarosa E, et al. Six-month oral dehydroepiandrosterone supplementa-tion in early and late postmenopause. Gynecol Endocrinol 2000;14:342–63
   PubMed Web of Science ®Google Scholar
• Baulieu EE, Thomas G, Legrain S, et al. Dehydro-epiandrosterone (DHEA), DHEA sulphate and ageing: contribution of the DHEAge study to a sociobiomedical issue. Proc Natl Acad Sci 2000; 97:3–8
   Web of Science ®Google Scholar
• Helzlsouer KJ, Gordon GB, Alberg A, et al. Relationship of prediagnostic serum levels of DHEA and DS to the risk of developing premenopausal breast cancer. Cancer Res 1992; 52:1–4
   PubMed Web of Science ®Google Scholar
• Bulbrook RD, Hayward JL, Spicer CC. Relation between urinary androgen and corticoid secretion excretion and subsequent breast cancer. Lancet 1975;2:395–8
   Google Scholar
• Thoman ML, Weigle WO. The cellular and sub-cellular bases of immunosenescence. Adv Immunol 1989;46:221–61
   PubMed Web of Science ®Google Scholar
• Egarter C, Sator M, Berghammer P, et al. Efficacy, tolerability, and rare side effects of tibolone treat-ment in postmenopausal women. Int J Gynecol Obstet 1999;64:281–6
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Petraglia F, Purdy RH. The brain: Source and Target for Sex Steroid Hormones. Carnforth, UK: Parthenon Publishing, 1996
   Google Scholar
• Ginzburg J, Hardiman P. Adrenergic agonist for menopausal complaints. In Genazzani AR, Montemagno U, Nappi C, eds. The Brain and Female Reproductive Function. Carnforth, UK: Parthenon Publishing, 1987:623–5
   Google Scholar
• Melis G, Cagnacci A, Gambacciani M. Restoration of luteinizing hormone response to naloxone in postmenopausal women by chronic administration of the antidopaminergic drug veralipride. J Clin Endocrinol Metab 1988;66:964–9
   Google Scholar
• Alonso-Solis R, Abreu, P, Leopez-Coviella I, et al. Gonadal steroid modulation of neuro endocrine transduction: a transynaptic view. Cell Mol Neurobiol 1996;3:357–82
   Google Scholar
• Krause JE, Bertics PJ, Karavolas HJ. Ovarian regulation of hypothalamic and pituitary pro gestin-metabolizing enzyme activities. Endo-crinology 1981;108:1–7
   Google Scholar
• Resko JA, Stadelman HL, Handa RJ. Control of 5-alpha-reduction of testosterone in neuroendo-crine tissues of female rats. Biol Reprod 1986; 34:870–7
   Google Scholar
• Malenndowicz LK. Sex differences in adreno-cortical structure and function. III. The effects of postpubertal go nadecto my and gonadal hormone replacement on adrenal cholesterol sidechain cleavage activity and on steroids biosynthesis by rat adrenal homogenates. Endokrinologie 1976;67: 26–35
   Google Scholar
• Cheng YJ, Karavolas HJ. Conversion of pro-gesterone to 5a-pregnane-3,20-dione and 3a-hydroxy-5a-pregnan-20-one by rat medial basal hypothalamus and the effects of estradiol and stage of estrus cycle on the conversion. Endocrinology 1973;93:1157–62
   PubMed Web of Science ®Google Scholar
• de Wit H, Schmitt L, Purdy R, et al. Effects of acute progesterone administration in healthy menopausal women and normally-cycling women. Psychoneuroendocrinology 2001;26:697–710
   PubMed Web of Science ®Google Scholar
• Kraemer RR, Synovitz LB, Gimpel T, et al. Effect of estrogen on serum DHEA in younger and older women and the relationship of DHEA to adiposity and gender. Metabolism 2001;50:488–93
   PubMed Web of Science ®Google Scholar
• Casson PR, Elkind-Hirsch KE, Buster JE, et al. Effect of postmenopausal estrogen replacement on circulating androgens. Obstet Gynecol 1997;90: 995–8
   PubMed Web of Science ®Google Scholar
• Komesaroff PA, Esler MD, Sudhir K. Estrogen supplementation attenuates gluco corticoid and catecholamine responses to mental stress in peri-menopausal women. J Clin Endocrinol Metab 1999;84:606–10
   Google Scholar
• Lindheim SR, Legro RS, Bernstein L, et al. Behavioral stress responses in premenopausal and p o stmenop aus al wo men and the effects o f estro gen. Am J Obstet Gynecol 1992;167:1831–6
   PubMed Web of Science ®Google Scholar
• Kicovic PM. New steroid for the climacteric syndrome. Minerva Endocrinol 1989;14:63–7
   PubMedGoogle Scholar
• Bernardi F, Lanzone A, Cento RI\4, et al. Allopregnanolone and dehydro epiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia. Eur J Endocrinol 2000;142:466–71
   Google Scholar